EU action on health

Improving health systems

Promoting good health

Pharmaceuticals and substances of human origin

Diseases and health threats

Risk assessment

Scientific committees

Endocrine disruptors

Endocrine disruptors

Biocides

Biocides

Key documents

07 November 2018

Towards a comprehensive European Union framework on endocrine disruptors

Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions
26 October 2017

Reply letter from Commissioner Andriukaitis to MEP La Via, chair of the EP ENVI Committee

The reply letter from Commissioner Andriukaitis to MEP La Via, chair of the EP ENVI Committee, explains the legal mandate of the Commission to amend the first paragraph of point 3.6.5 of annex II to Regulation (EC) No 1107/2009.
26 October 2017

Reply letter from Commissioner Andriukaitis to the Chair of the Committee on the Environment, Public Health and Food Safety, Ms Adina-Ioana Vălean

The reply letter from Commissioner Andriukaitis to the Chair of the Committee on the Environment, Public Health and Food Safety, Ms Adina-Ioana Vălean, confirmed that any biocidal product that has endocrine-disrupting properties cannot be authorised for making available on the market for use by the general public.

The scrutiny of the Council and the European Parliament on the Delegated Regulation ended on 4 November 2017, as neither of them requested an extension for a further two months. Neither the Council nor the European Parliament objected to the Delegated Regulation.